山东大学耳鼻喉眼学报 ›› 2026, Vol. 40 ›› Issue (1): 95-98.doi: 10.6040/j.issn.1673-3770.0.2024.375

• 论著 • 上一篇    

原发性鼻腔高级别非肠型腺癌1例并文献复习

彭中华,陈竹,袁洛花,余绍兰,马玉玲   

  1. 四川省妇幼保健院 耳鼻咽喉科, 四川 成都 610031
  • 发布日期:2026-02-13
  • 通讯作者: 袁洛花. E-mail:5251062@qq.com

Primary high-grade non-intestinal-type adenocarcinoma of the nasal cavity: a case report and review of the literature

PENG Zhonghua, CHEN Zhu, YUAN Luohua, YU Shaolan, MA Yuling   

  1. Department of Otorhinolaryngology, Sichuan Provincial Maternal and Child Health Care Hospital, Sichuan 610031, Chengdu, China
  • Published:2026-02-13

摘要: 目的 探讨鼻腔鼻窦非肠型腺癌的临床病理特征、诊断和治疗方法。 方法 回顾分析1例鼻腔高级别非肠型腺癌患儿的临床表现、影像学、病理学及随访资料,同时结合文献总结鼻腔鼻窦非肠型腺癌的诊疗思路及预后。 结果 患者经鼻内镜行左侧鼻腔肿物切除术+鼻窦开放术,术后病理示鼻腔恶性肿瘤,免疫组化示CK7阳性,CK20、CDX2、S0X10阴性,随访患者未见复发。 结论 鼻腔鼻窦高级别非肠型腺癌罕见,病理活检是诊断的金标准;治疗手段主要为手术彻底切除,切缘阴性是影响预后的关键因素。

关键词: 鼻腔肿瘤, 高级别非肠型腺癌, 腺癌, 病理特征, 预后

Abstract: Objective To explore the clinicopathological characteristics, diagnosis, and therapies of non-intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Methods Retrospectively analyzed the clinical presentation, imaging manifestations, pathological findings, and follow-up data of a pediatric case of high-grade NITA. Summarize the diagnosis and treatment strategies, as well as the prognosis of NITA of the nasal cavity and paranasal sinuses, based on literature reviews. Results The patient underwent tumor resection of the left nasal cavity + sinus opening surgery by nasal endoscopy. Postoperative pathology confirmed a malignant nasal cavity tumor, immunohistochemistry showing positivity for CK7 and negativity for CK20, CDX2 and SOX10. No recurrence was observed during follow-up. Conclusion High-grade NITA of the nasal cavity and paranasal sinuses is rare, and pathological biopsy remains the gold standard for diagnosis. Complete surgical resection with negative margins is the primary treatment, and the state of the margins is a critical prognostic factor.

Key words: Nasal cavity neoplasms, High-grade non-intestinal-type adenocarcinoma, Adenocarcinoma, Pathological characteristics, Prognosis

中图分类号: 

  • R739.62
[1] Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data[J]. Head Neck, 2012, 34(6): 877-885. doi:10.1002/hed.21830
[2] Adel KE, John KC, Jennifer RG, et al. WHO classification of head and neck tumours [M]. Lyon: IARC Press, 2017: 24-26
[3] 牛建瑛, 陈勇, 李平栋. 鼻腔鼻窦肠型腺癌中表皮生长因子受体蛋白表达及相关基因突变分析[J]. 中国耳鼻咽喉头颈外科, 2015, 22(11): 569-573. doi:10.16066/j.1672-7002.2015.11.008 NIU Jianying, CHEN Yong, LI Pingdong. Epidermal growth factor receptor expression and KRAS and BRAF mutations in sinonasal intestinal-type adenocarcinomas[J]. Chinese Archives of Otolaryngology-Head and Neck Surgery, 2015, 22(11): 569-573. doi:10.16066/j.1672-7002.2015.11.008
[4] 杨文圣, 陈静, 林蓁. 鼻腔鼻窦高级别非肠型腺癌临床病理观察[J/OL]. 中华临床医师杂志(电子版), 2019, 13(10): 761-766. doi:10.3877/cma.j.issn.1674-0785.2019.10.010 YANG Wensheng, CHEN Jing, LIN Zhen. Clinicopathologic observation of sinonasal high-grade non-intestinal type adenocarcinoma[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2019, 13(10): 761-766. doi:10.3877/cma.j.issn.1674-0785.2019.10.010
[5] 岳常丽, 朴颖实, 白玉萍, 等. CK7、CK20、SOX10和CDX2在鼻腔鼻窦原发腺癌中的表达及诊断价值[J]. 中华医学杂志, 2015, 95(30): 2447-2450. doi:10.3760/cma.j.issn.0376-2491.2015.30.009 YUE Changli, PIAO Yingshi, BAI Yuping, et al. CK7, CK20, SOX10 and CDX2: expressions and diagnostic values in primary adenocarcinoma of the sinonasal tract[J]. Natl Med J China, 2015, 95(30): 2447-2450. doi:10.3760/cma.j.issn.0376-2491.2015.30.009
[6] Bignami M, Lepera D, Volpi L, et al. Sinonasal non-intestinal-type adenocarcinoma: a retrospective review of 22 patients[J]. World Neurosurg, 2018, 120: 962-969. doi:10.1016/j.wneu.2018.08.201
[7] Bonzini M, Facchinetti N, Zanetta L, et al. Tumori nasosinusali diversi da adenocarcinoma di tipo intestinale ed esposizione a cancerogeni professionali: uno studio caso-controllo[J]. Med Lav., 2016, 107(5): 331-339
[8] Purgina B, Bastaki JM, Duvvuri U, et al. A subset of sinonasal non-intestinal type adenocarcinomas are truly seromucinous adenocarcinomas: a morphologic and immunophenotypic assessment and description of a novel pitfall[J]. Head Neck Pathol, 2015, 9(4): 436-446. doi:10.1007/s12105-015-0615-3
[9] 周斌, 吴罗燕, 叶东梅, 等. 原发性鼻腔鼻窦腺癌15例临床病理分析[J]. 诊断病理学杂志, 2023, 30(8): 783-787. doi:10.3969/j.issn.1007-8096.2023.08.014 ZHOU Bin, WU Luoyan, YE Dongmei, et al. Clinicopathological features of primary adenocarcinoma of the nasal cavity and sinuses in 15 cases[J]. Chinese Journal of Diagnostic Pathology, 2023, 30(8): 783-787. doi:10.3969/j.issn.1007-8096.2023.08.014
[10] 张慧芝, 敖爽, 王淑妍, 等. 原发性鼻腔鼻窦腺癌12例临床病理分析[J]. 临床与实验病理学杂志, 2020, 36(8): 966-969. doi:10.13315/j.cnki.cjcep.2020.08.021
[11] Li JM, Li BF, Xu J, et al. A retrospective review of non-intestinal-type adenocarcinoma of nasal cavity and paranasal sinus[J]. Oncol Lett, 2023, 25(3): 132. doi:10.3892/ol.2023.13718
[12] 陈娜, 吕威, 查洋, 等. 鼻腔鼻窦非肠型腺癌6例临床分析[J]. 中国耳鼻咽喉颅底外科杂志, 2021, 27(3): 285-288. doi:10.11798/j.issn.1007-1520.202121014 CHEN Na, LYU Wei, ZHA Yang, et al. Sinonasal non-intestinal type adenocarcinoma of the nasal cavity and paranasal sinuses: clinical analysis of 6 cases[J]. Chin J Otorhinolaryngol Skull Base Surg, 2021, 27(3): 285-288. doi:10.11798/j.issn.1007-1520.202121014
[13] Nicolai P, Schreiber A, Bolzoni Villaret A, et al. Intestinal type adenocarcinoma of the ethmoid: outcomes of a treatment regimen based on endoscopic surgery with or without radiotherapy[J]. Head Neck, 2016, 38: 996-1003. doi:10.1002/hed.24144
[14] Bhayani MK, Yilmaz T, Sweeney A, et al. Sinonasal adenocarcinoma: a 16-year experience at a single institution[J]. Head Neck, 2014, 36(10): 1490-1496. doi:10.1002/hed.23485
[15] Lund VJ, Chisholm EJ, Takes RP, et al. Evidence for treatment strategies in sinonasal adenocarcinoma[J]. Head Neck, 2012, 34(8): 1168-1178. doi:10.1002/hed.21770
[16] Bogaerts S, Vander Poorten V, Nuyts S, et al. Results of endoscopic resection followed by radiotherapy for primarily diagnosed adenocarcinomas of the paranasal sinuses[J]. Head Neck, 2008, 30(6): 728-736. doi:10.1002/hed.20771
[1] 缪红利,张妍春,郝琳娜,唐乐,何英楠. 活动性眼弓形虫病临床特征及预后分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 82-89.
[2] 李赞,卢奇,申卫东,侯昭晖,吴南. 坏死性外耳道炎临床诊治18例[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 17-22.
[3] 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137.
[4] 张中华,王辉,王俊鑫,张美玲,张建,张恩东,潘新良. 腋窝入路腔镜手术和传统颈部开放手术治疗T1甲状腺癌的安全性和有效性对比研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 161-167.
[5] 杨鸣,刘雪霞,张华. m6A识别蛋白IGF2BPs家族在头颈肿瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 153-161.
[6] 黄佳丽,刘梓琪,徐娟,陈曦,张立庆,周涵. 咽部梭形细胞鳞状细胞癌的临床及预后分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 94-100.
[7] 李美辰,陈海玲,李阳,马登殿. 下鼻甲黏液囊肿1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 91-94.
[8] 杨开炎, 唐凤珠, 覃启才, 李旭祥, 冯大益, 农丰靖, 杨秋云. 异常纺锤体样小头畸形相关蛋白在鼻咽癌中的表达及其临床意义[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 18-25.
[9] 王凯健,陈雪生,王威. 血小板-淋巴细胞比值与喉鳞状细胞癌预后相关性的Meta分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 67-73.
[10] 张佳佳,石安妮,邢御,洪玉颖,白鹏. 针刺联合西药治疗全聋型突发性聋1例与文献复习[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 88-92.
[11] 胡婷婷,王越华. 阻塞性睡眠呼吸暂停与乳腺癌相关性研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(6): 41-45.
[12] 孙洁,肖旭平,李云秋. 鼻腔低级别非肠型腺癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 26-30.
[13] 张永红,张辉,王彩华,杨欣欣,吴允刚,赵玉凤,庞太忠,李晓瑜. 基于TCGA数据库构建喉鳞状细胞癌免疫相关基因预后模型及筛选靶向分子药物[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 54-62.
[14] 刘楠,逄明杰. 鼻内镜泪囊鼻腔吻合术预后影响因素的研究进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 149-155.
[15] 吴波,黄天德,闫斌,陈伊,汤勇. 焦虑抑郁状态与特发性耳鸣预后的相关性研究[J]. 山东大学耳鼻喉眼学报, 2023, 37(4): 46-52.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!